Interestingly, LRRK2 protein levels are increased in B cells, T cells (CD4+, CD8+, and T regulatory cells) and CD14+ as well as CD16+ monocytes in PD patients compared to healthy controls (Bliederhaeuser et al., 2016; Cook et al., 2017). Here, LRRK2 is linked to Parkinson disease.